Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Yueyu Cao"'
Publikováno v:
Genomics Data, Vol 8, Iss C, Pp 16-17 (2016)
Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of primary effusion lymphoma (PEL), a rapidly progressing malignancy mostly arising in HIV-infected patients Chen et al. (2007) [1]. Even under conventional chemotherapy, PEL con
Externí odkaz:
https://doaj.org/article/e97ada7530e0421c9a3fb373f7de3615
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e101326 (2014)
Kaposi's sarcoma (KS) remains the most common tumor arising in patients with HIV/AIDS, and involvement of the oral cavity represents one of the most common clinical manifestations of this tumor. HIV infection incurs an increased risk for periodontal
Externí odkaz:
https://doaj.org/article/7e6ffc9d5e774ab5a351ea75e7ea57cb
Autor:
Zhenkun Lou, Guoliang Pi, Junqiu Yue, Sheng Hu, Lifeng Chen, Qian Zhu, Yu Shi, Jing Hou, Wootae Kim, Min Deng, Kuntian Luo, Ping Yin, Mingwei Wang, Kai Zhang, Li Liu, Jinzhou Huang, Fei Zhao, Qin Zhou, Guijie Guo, Yueyu Cao, Jake A. Kloeber, Qiang Guo, Chao Zhang, Wenzhuan Xie, Ting Wei, Xinyi Tu, Bin Yang, Shuang Dong, Manxiang Wang, Xiangyu Zeng, Qifan Yang, Yong Zhang
Effects of MET and STING signals on MET OE tumor after the intervention of MET inhibitor in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f3b124eb886f2c431f927aec2825645
https://doi.org/10.1158/2159-8290.22540844.v1
https://doi.org/10.1158/2159-8290.22540844.v1
Autor:
Zhenkun Lou, Guoliang Pi, Junqiu Yue, Sheng Hu, Lifeng Chen, Qian Zhu, Yu Shi, Jing Hou, Wootae Kim, Min Deng, Kuntian Luo, Ping Yin, Mingwei Wang, Kai Zhang, Li Liu, Jinzhou Huang, Fei Zhao, Qin Zhou, Guijie Guo, Yueyu Cao, Jake A. Kloeber, Qiang Guo, Chao Zhang, Wenzhuan Xie, Ting Wei, Xinyi Tu, Bin Yang, Shuang Dong, Manxiang Wang, Xiangyu Zeng, Qifan Yang, Yong Zhang
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de57103c548c4fff9c6da482bf1b19b0
https://doi.org/10.1158/2159-8290.22540832
https://doi.org/10.1158/2159-8290.22540832
Autor:
Zhenkun Lou, Guoliang Pi, Junqiu Yue, Sheng Hu, Lifeng Chen, Qian Zhu, Yu Shi, Jing Hou, Wootae Kim, Min Deng, Kuntian Luo, Ping Yin, Mingwei Wang, Kai Zhang, Li Liu, Jinzhou Huang, Fei Zhao, Qin Zhou, Guijie Guo, Yueyu Cao, Jake A. Kloeber, Qiang Guo, Chao Zhang, Wenzhuan Xie, Ting Wei, Xinyi Tu, Bin Yang, Shuang Dong, Manxiang Wang, Xiangyu Zeng, Qifan Yang, Yong Zhang
Baseline characteristics of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c9e681e22682e09d1b97d7bd934d414
https://doi.org/10.1158/2159-8290.22540829.v1
https://doi.org/10.1158/2159-8290.22540829.v1
Autor:
Zhenkun Lou, Guoliang Pi, Junqiu Yue, Sheng Hu, Lifeng Chen, Qian Zhu, Yu Shi, Jing Hou, Wootae Kim, Min Deng, Kuntian Luo, Ping Yin, Mingwei Wang, Kai Zhang, Li Liu, Jinzhou Huang, Fei Zhao, Qin Zhou, Guijie Guo, Yueyu Cao, Jake A. Kloeber, Qiang Guo, Chao Zhang, Wenzhuan Xie, Ting Wei, Xinyi Tu, Bin Yang, Shuang Dong, Manxiang Wang, Xiangyu Zeng, Qifan Yang, Yong Zhang
Immune checkpoint blockade (ICB) has revolutionized cancer therapy. However, the response of patients to ICB is difficult to predict. Here, we examined 81 patients with lung cancer under ICB treatment and found that patients with MET amplification we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7eb0549ac33149e043ee778cb86372f1
https://doi.org/10.1158/2159-8290.c.6549485.v1
https://doi.org/10.1158/2159-8290.c.6549485.v1
Autor:
Xiangyu Zeng, Fei Zhao, Gaofeng Cui, Yong Zhang, Rajashree A. Deshpande, Yuping Chen, Min Deng, Jake A. Kloeber, Yu Shi, Qin Zhou, Chao Zhang, Jing Hou, Wootae Kim, Xinyi Tu, Yuanliang Yan, Zhijie Xu, Lifeng Chen, Huanyao Gao, Guijie Guo, Jiaqi Liu, Qian Zhu, Yueyu Cao, Jinzhou Huang, Zheming Wu, Shouhai Zhu, Ping Yin, Kuntian Luo, Georges Mer, Tanya T. Paull, Jian Yuan, Kaixiong Tao, Zhenkun Lou
Publikováno v:
Nature cancer. 3(9)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers. Characterization of genetic alterations will improve our understanding and therapies for this disease. Here, we report that PDAC with elevated expression of METTL16, one of th
Autor:
Guijie Guo, Yu Shi, Fei Zhao, Jake A. Kloeber, Yueyu Cao, Xiangyu Zeng, Junqiu Yue, Li Liu, Kuntian Luo, Xinyi Tu, Yong Zhang, Ping Yin, Ting Wei, Guoliang Pi, Mingwei Wang, Zhenkun Lou, Jing Hou, Manxiang Wang, Qifan Yang, Chao Zhang, Sheng Hu, Wootae Kim, Jinzhou Huang, Min Deng, Qin Zhou, Kai Zhang, Shuang Dong, Lifeng Chen, Bin Yang, Qian Zhu, Guo Qiang, Wenzhuan Xie
Publikováno v:
Cancer discovery. 11(11)
Immune checkpoint blockade (ICB) has revolutionized cancer therapy. However, the response of patients to ICB is difficult to predict. Here, we examined 81 patients with lung cancer under ICB treatment and found that patients with MET amplification we
Publikováno v:
Journal of Cancer
Kaposi's Sarcoma-associated Herpesvirus (KSHV) is the etiologic agent of several human malignancies, particularly Kaposi's Sarcoma (KS), which preferentially arise in immunocompromised patients such as HIV+ subpopulation while still lacking of effect
Publikováno v:
Oncotarget
Non-small cell lung cancer (NSCLC) accounts for about 85-90% of lung cancer cases, which represents the leading cause of cancer-related death in the world. The majority of lung cancer patients doesn't respond well to conventional chemo-/radio-therape